Figure 1From: Definitive 3D-CRT for clinically localized prostate cancer: modifications of the clinical target volume following a prostate MRI and the clinical benefitsThe 5-year biochemical relapse-free survival rates between the patients with and without a prostate MRI were 86 and 90%, respectively; there were no significant differences.Back to article page